Literature DB >> 25443119

Implementing hexaminolevulinate HCl blue light cystoscopy: a nursing perspective.

Anne E Calvaresi, Edouard J Trabulsi, Maryann Sonzogni, Leonard G Gomella, Costas D Lallas, Kristen S Wachsmuth.   

Abstract

Hexaminolevulinate HCl is a diagnostic imaging agent used with blue light during cystoscopy to help detect non-muscle-invasive bladder cancer. Blue light cystoscopy performed using hexaminolevulinate HCl has been found to detect more papillary non-muscle-invasive bladder tumors than cystoscopy performed using standard white light. Because bladder instillation and retention requirements of hexaminolevulinate during cystoscopy can affect patient flow in the perioperative setting, this technique necessitates changes in nursing practice and care of patients with known or suspected non-muscle-invasive bladder cancer. Nursing personnel at one facility followed the AORN guidelines for preoperative patient care in the ambulatory setting to address staffing, preoperative nursing assessment, anesthesia evaluation, and preoperative teaching related to implementing blue light cystoscopy.
Copyright © 2014 AORN, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bladder cancer; blue light cystoscopy; cystoscopy; hematuria; hexaminolevulinate

Mesh:

Substances:

Year:  2014        PMID: 25443119     DOI: 10.1016/j.aorn.2013.12.013

Source DB:  PubMed          Journal:  AORN J        ISSN: 0001-2092            Impact factor:   0.676


  1 in total

1.  Effects of Nursing Care for the Treatment of Patients with Bladder Cancer: A Systematic Review and Meta-analysis.

Authors:  Zhe Gao; Liang Fang; Peiyi Yin; Yan Deng; Mengting Pei; Tiantian Zhou
Journal:  Comput Math Methods Med       Date:  2022-09-25       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.